Document Detail


Mutations in the AGXT2L2 gene cause phosphohydroxylysinuria.
MedLine Citation:
PMID:  23242558     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Phosphohydroxylysinuria has been described in two patients with neurological symptoms, but the deficient enzyme or mutated gene has never been identified. In the present work, we tested the hypothesis that this condition is due to mutations in the AGXT2L2 gene, recently shown to encode phosphohydroxylysine phospholyase. DNA analysis from a third patient, without neurological symptoms, but with an extreme hyperlaxicity of the joints, shows the existence of two mutations, p. Gly240Arg and p.Glu437Val, both in the heterozygous state. Sequencing of cDNA clones derived from fibroblasts mRNA indicated that the two mutations were allelic. Both mutations replace conserved residues. The mutated proteins were produced as recombinant proteins in Escherichia coli and HEK293T cells and shown to be very largely insoluble, whereas the wild-type one was produced as a soluble and active protein. We conclude that phosphohydroxylysinuria is due to mutations in the AGXT2L2 gene and the resulting lack of activity of phosphohydroxylysine phospholyase in vivo. The finding that the nul alleles of p.Gly240Arg and p.Glu437Val are present at low frequencies in the European and/or North American population suggests that this condition is more common than previously thought. The diversity of the clinical symptoms described in three patients with phosphohydroxylysinuria indicates that this is most likely not a neurometabolic disease.
Authors:
Maria Veiga-da-Cunha; Nanda M Verhoeven-Duif; Tom J de Koning; Marinus Duran; Bert Dorland; Emile Van Schaftingen
Related Documents :
24613578 - A new turkish infant with clinical features of cs/ciss1 syndrome and homozygous crlf1 m...
18215208 - Charcot-marie-tooth disease: a clinico-genetic confrontation.
23597578 - Genetic predisposition to molecular response in patients with myeloproliferative neopla...
24737308 - Lack of noncanonical ras mutations in cytogenetically normal acute myeloid leukemia.
22553928 - Association between the cd209 promoter -336a/g polymorphism and susceptibility to tuber...
24613578 - A new turkish infant with clinical features of cs/ciss1 syndrome and homozygous crlf1 m...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-14
Journal Detail:
Title:  Journal of inherited metabolic disease     Volume:  -     ISSN:  1573-2665     ISO Abbreviation:  J. Inherit. Metab. Dis.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7910918     Medline TA:  J Inherit Metab Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Laboratory of Physiological Chemistry, de Duve Institute and Université Catholique de Louvain, Avenue Hippocrate 75, 1200, Brussels, Belgium, maria.veiga@uclouvain.be.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Microarray analysis identifies COMP as the most differentially regulated transcript throughout in vi...
Next Document:  Verification of correct central venous catheter placement in the emergency department: comparison be...